WHO has expanded the use of Chinese manufacturer SINOVAC Biotech’s COVID-19 vaccine for children aged 3-17, making it the first and only vaccine on the WHO’s Emergency Use Listing (EUL) that has been recommended for children aged 3-4.
WHO extends coverage of SINOVAC’s COVID-19 vaccine for 3-year-olds
